论文部分内容阅读
目的:了解糖化血红蛋白(HbAlc)检测和控制血糖的临床意义。方法:采用免疫比浊法。结果:130例糖尿痛(DM)患者对照组均≤6.5%,糖尿病患者组HbAlc有300例均<6.5%。有144例≥10%。结论糖化血红蛋白作为糖尿病患者血糖水平监测和治疗的指标,具有重要的临床意义和使用价值。
Objective: To understand the clinical significance of HbAlc in detecting and controlling blood sugar. Methods: Immunoturbidimetry was used. Results: The control group of 130 patients with diabetes mellitus (DM) were both less than 6.5%, while those with diabetes were all less than 6.5% of the 300 patients with HbA1c. 144 cases ≥ 10%. Conclusion Glycated hemoglobin as an indicator of blood glucose monitoring and treatment in patients with diabetes has important clinical significance and value.